3 Reasons FireEye Inc. Stock Could Fall
/
Date23 Dec 2016
Image source: Getty Images. At a glance, FireEye (NASDAQ: FEYE) might look like a relatively solid buy for investors interested in the cybersecurity industry. Its... Read More →
Notifications on the disposal and acquisition of voting rights
/
Date23 Dec 2016
Vilnius, Lithuania, 2016-12-23 15:31 CET (GLOBE NEWSWIRE) — INVL Technology has received from Invalda INVL notification of a person on disposal of voting rights and... Read More →
Novo Nordisk A/S – Share repurchase programme
/
Date23 Dec 2016
Company announcement no. 89 / 2016.pdf Bagsværd, Denmark, 23 December 2016 – On 28 October 2016, Novo Nordisk initiated a share repurchase programme in accordance... Read More →
WisdomTree ETFs Declare Distributions
/
Date23 Dec 2016
NEW YORK, Dec. 23, 2016 (GLOBE NEWSWIRE) — WisdomTree (NASDAQ:WETF) today announced that WisdomTree declared distributions for the following WisdomTree ETFs. Rates are listed below:... Read More →
Pranešimai apie akcijų paketo netekimą ir įgijimą
/
Date23 Dec 2016
Vilnius, Lietuva, 2016-12-23 15:31 CET (GLOBE NEWSWIRE) — „INVL Technology“ gavo „Invaldos INVL“, kaip asmens, pranešimą apie akcijų paketo netekimą ir „INVL Asset Management“ bei... Read More →
Hybrid’s Technology Is Featured In Prestigious European Polymer Journal
/
Date23 Dec 2016
SAN FRANCISCO, Dec. 23, 2016 (GLOBE NEWSWIRE) — Hybrid Coating Technologies Inc. (OTC Pink:HCTI) is pleased to announce that its Green Polyurethane technology was recently... Read More →
Guaranty Federal Bancshares, Inc. Announces Quarterly Dividend
/
Date23 Dec 2016
SPRINGFIELD, Mo., Dec. 23, 2016 (GLOBE NEWSWIRE) — Guaranty Federal Bancshares, Inc., (NASDAQ:GFED), the holding company (the “Company”) for Guaranty Bank, today announces a dividend... Read More →
Strongbridge Biopharma plc Announces Acquisition of U.S. Rights to KEVEYIS® From Taro
/
Date23 Dec 2016
~ KEVEYIS is the First and Only FDA-Approved Treatment for Hyperkalemic, Hypokalemic, and Related Variants of Primary Periodic Paralysis, an Ultra-Orphan, Genetic Neuromuscular Disease ~... Read More →
Neothetics Initiates Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous Fat
/
Date23 Dec 2016
SAN DIEGO, Dec. 23, 2016 (GLOBE NEWSWIRE) — Neothetics, Inc. (NASDAQ:NEOT) today announced the initiation of the Phase 2 proof of concept trial, LIPO-202-CL-31, for... Read More →
Preferred Bank Increases Quarterly Cash Dividend
/
Date23 Dec 2016
LOS ANGELES, Dec. 23, 2016 (GLOBE NEWSWIRE) — Preferred Bank (NASDAQ:PFBC), an independent commercial bank focusing on the diversified California market, today reported that the... Read More →